158 related articles for article (PubMed ID: 17209056)
1. Inhibition of HIV-1 infection by viral chemokine U83A via high-affinity CCR5 interactions that block human chemokine-induced leukocyte chemotaxis and receptor internalization.
Catusse J; Parry CM; Dewin DR; Gompels UA
Blood; 2007 May; 109(9):3633-9. PubMed ID: 17209056
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of U83A viral chemokine, a broad and potent beta-chemokine agonist for human CCRs with unique selectivity and inhibition by spliced isoform.
Dewin DR; Catusse J; Gompels UA
J Immunol; 2006 Jan; 176(1):544-56. PubMed ID: 16365449
[TBL] [Abstract][Full Text] [Related]
3. Activation of CCR2+ human proinflammatory monocytes by human herpesvirus-6B chemokine N-terminal peptide.
Clark DJ; Catusse J; Stacey A; Borrow P; Gompels UA
J Gen Virol; 2013 Jul; 94(Pt 7):1624-1635. PubMed ID: 23535574
[TBL] [Abstract][Full Text] [Related]
4. CCR5 signalling, but not DARC or D6 regulatory, chemokine receptors are targeted by herpesvirus U83A chemokine which delays receptor internalisation via diversion to a caveolin-linked pathway.
Catusse J; Clark DJ; Gompels UA
J Inflamm (Lond); 2009 Jul; 6():22. PubMed ID: 19643012
[TBL] [Abstract][Full Text] [Related]
5. Agonist-induced internalization of CC chemokine receptor 5 as a mechanism to inhibit HIV replication.
Ferain T; Hoveyda H; Ooms F; Schols D; Bernard J; Fraser G
J Pharmacol Exp Ther; 2011 Jun; 337(3):655-62. PubMed ID: 21389095
[TBL] [Abstract][Full Text] [Related]
6. Selective recruitment of Th2-type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein-II.
Weber KS; Gröne HJ; Röcken M; Klier C; Gu S; Wank R; Proudfoot AE; Nelson PJ; Weber C
Eur J Immunol; 2001 Aug; 31(8):2458-66. PubMed ID: 11500830
[TBL] [Abstract][Full Text] [Related]
7. Expression and function of chemokine receptors on human thymocytes: implications for infection by human immunodeficiency virus type 1.
Taylor JR; Kimbrell KC; Scoggins R; Delaney M; Wu L; Camerini D
J Virol; 2001 Sep; 75(18):8752-60. PubMed ID: 11507220
[TBL] [Abstract][Full Text] [Related]
8. Multiple determinants are involved in HIV coreceptor use as demonstrated by CCR4/CCL22 interaction in peripheral blood mononuclear cells (PBMCs).
Agrawal L; Vanhorn-Ali Z; Alkhatib G
J Leukoc Biol; 2002 Nov; 72(5):1063-74. PubMed ID: 12429730
[TBL] [Abstract][Full Text] [Related]
9. The lupane-type triterpene 30-oxo-calenduladiol is a CCR5 antagonist with anti-HIV-1 and anti-chemotactic activities.
Barroso-González J; El Jaber-Vazdekis N; García-Expósito L; Machado JD; Zárate R; Ravelo ÁG; Estévez-Braun A; Valenzuela-Fernández A
J Biol Chem; 2009 Jun; 284(24):16609-16620. PubMed ID: 19386595
[TBL] [Abstract][Full Text] [Related]
10. HIV type 1 glycoprotein 120 inhibits human B cell chemotaxis to CXC chemokine ligand (CXCL) 12, CC chemokine ligand (CCL)20, and CCL21.
Badr G; Borhis G; Treton D; Moog C; Garraud O; Richard Y
J Immunol; 2005 Jul; 175(1):302-10. PubMed ID: 15972662
[TBL] [Abstract][Full Text] [Related]
11. Agonist-induced endocytosis of CC chemokine receptor 5 is clathrin dependent.
Signoret N; Hewlett L; Wavre S; Pelchen-Matthews A; Oppermann M; Marsh M
Mol Biol Cell; 2005 Feb; 16(2):902-17. PubMed ID: 15591129
[TBL] [Abstract][Full Text] [Related]
12. gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors.
Catani MV; Corasaniti MT; Navarra M; Nisticò G; Finazzi-Agrò A; Melino G
J Neurochem; 2000 Jun; 74(6):2373-9. PubMed ID: 10820198
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines.
Colin P; Bénureau Y; Staropoli I; Wang Y; Gonzalez N; Alcami J; Hartley O; Brelot A; Arenzana-Seisdedos F; Lagane B
Proc Natl Acad Sci U S A; 2013 Jun; 110(23):9475-80. PubMed ID: 23696662
[TBL] [Abstract][Full Text] [Related]
14. Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction.
Grainger DJ; Lever AM
Retrovirology; 2005 Apr; 2():23. PubMed ID: 15807900
[TBL] [Abstract][Full Text] [Related]
15. Receptor conformation and constitutive activity in CCR5 chemokine receptor function and HIV infection.
Flanagan CA
Adv Pharmacol; 2014; 70():215-63. PubMed ID: 24931198
[TBL] [Abstract][Full Text] [Related]
16. Effect of CCR5 receptor antagonists on endocytosis of the human CCR5 receptor in CHO-K1 cells.
Longden J; Cooke EL; Hill SJ
Br J Pharmacol; 2008 Apr; 153(7):1513-27. PubMed ID: 18223665
[TBL] [Abstract][Full Text] [Related]
17. Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization.
Szabo I; Wetzel MA; Zhang N; Steele AD; Kaminsky DE; Chen C; Liu-Chen LY; Bednar F; Henderson EE; Howard OM; Oppenheim JJ; Rogers TJ
J Leukoc Biol; 2003 Dec; 74(6):1074-82. PubMed ID: 12972507
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide inhibits HIV-1 infection of monocyte- derived macrophages through direct and sustained down-regulation of CC chemokine receptor 5.
Franchin G; Zybarth G; Dai WW; Dubrovsky L; Reiling N; Schmidtmayerova H; Bukrinsky M; Sherry B
J Immunol; 2000 Mar; 164(5):2592-601. PubMed ID: 10679098
[TBL] [Abstract][Full Text] [Related]
19. In vitro effect of anti-human immunodeficiency virus CCR5 antagonist maraviroc on chemotactic activity of monocytes, macrophages and dendritic cells.
Rossi R; Lichtner M; De Rosa A; Sauzullo I; Mengoni F; Massetti AP; Mastroianni CM; Vullo V
Clin Exp Immunol; 2011 Nov; 166(2):184-90. PubMed ID: 21985364
[TBL] [Abstract][Full Text] [Related]
20. Blocking CC chemokine receptor (CCR) 1 and CCR5 during herpes simplex virus type 2 infection in vivo impairs host defence and perturbs the cytokine response.
Sørensen LN; Paludan SR
Scand J Immunol; 2004 Mar; 59(3):321-33. PubMed ID: 15030585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
